Title : Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir.

Pub. Date : 2014 Oct

PMID : 23957840






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We investigated whether erythropoietin (EPO) could alleviate RBV-induced anemia to help maintain the RBV dose during the first 12 weeks, the triple therapy phase. Ribavirin erythropoietin Homo sapiens
2 We investigated whether erythropoietin (EPO) could alleviate RBV-induced anemia to help maintain the RBV dose during the first 12 weeks, the triple therapy phase. Ribavirin erythropoietin Homo sapiens
3 We investigated whether erythropoietin (EPO) could alleviate RBV-induced anemia to help maintain the RBV dose during the first 12 weeks, the triple therapy phase. Ribavirin erythropoietin Homo sapiens
4 We investigated whether erythropoietin (EPO) could alleviate RBV-induced anemia to help maintain the RBV dose during the first 12 weeks, the triple therapy phase. Ribavirin erythropoietin Homo sapiens